Document is current
Any future updates will be listed below
-
Authors
Nishiyama, Hiroyuki
Inoue, Takamitsu
Koizumi, Yuichi
Kobayashi, Yusuke
Kitamura, Hiroshi
Yamamoto, Kazuhiro
Takeda, Takashi
Yamamoto, Takehito
Yamamoto, Ryohei
Matsubara, Takeshi https://orcid.org/0000-0002-2380-1551
Hoshino, Junichi
Yanagita, Motoko
,
- License Information
-
More Information
Article History
Received: 26 May 2023
Accepted: 25 June 2023
First Online: 12 August 2023
Declarations
:
: H.N has received honoraria from MSD K.K., Astellas pharma Inc., and Merck Biopharma Co., Ltd., research fundings from Chugai Pharmaceutical Co. Ltd., and a scholarship donation from Bayer AG. H. Kitamura has received honoraria from Astellas Pharma Inc, Takeda Pharmaceutical Company Limited, Bayer AG, and Janssen Pharmaceutical K.K., and scholarship donations from Takeda Pharmaceutical Company Limited and Bayer AG. J.H has received honoraria from Kyowa Kirin Co., Ltd., Mitsubishi Tanabe Pharma, Ono Pharm, AstraZeneca and Astellas Pharma Inc, and a research grant from Otsuka Pharmaceutical Co., Ltd. M. Yanagita has received honoraria from Astellas Pharma Inc, AstraZeneca, Kyowa Kirin Co., Ltd., Chugai-Pharmaceutical Co., Ltd., Bayer AG, and Mitsubishi Tanabe Pharma, and research grants from Mitsubishi Tanabe Pharma, Boehringer Ingelheim International GmbH, and scholarship donations from Kyowa Kirin Co., Ltd., Chugai-Pharmaceutical Co., Ltd., and Mitsubishi Tanabe Pharma. The other authors declare no potential conflicts of interest.
